TickerTalks
Browse all tickers →
TickerTalks›$ISPR
ISISPR

Ispire Technology Inc.

$ISPR·$71M·Tobacco·Consumer Defensive
$1.63+7.9%YTD-40.9%1Y-44.7%
Mentions · last 7 days
2026-07-03: 0 posts2026-07-04: 0 posts2026-07-05: 1 posts2026-07-06: 0 posts2026-07-07: 0 posts2026-07-08: 2 posts2026-07-09: 3 posts6+200%
Price updated 13h ago·X counts updated 2d ago
ISISPR
$ISPRIspire Technology Inc.
$1.63+7.95%6 posts+200%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $ISPR, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Broken storyCooling offAI verdict · as of 2026-07-11

Catching its breath after a run — could pick back up or fade from here.

Ispire Technology with Q3 revenue -29% YoY and a nicotine-pouch JV pivot — the vape microcap is contracting and the pivot is unproven.

Ispire Technology is the vaping-hardware manufacturer for electronic cigarettes and cannabis devices. The current setup is a broken-tape microcap trying to pivot into the nicotine-pouch category through partnership.

  • Fundamentals confirm the contraction: Q3 revenue declined 29% year-over-year to $18.7M with -51% operating margin — the operating base is shrinking meaningfully on the regulatory-and-competition pressure in vape.
  • The Jincheng Pharma nicotine-pouch JV is the specific commercial catalyst: real dated commercial-partnership expansion into a growing adjacent category, though the JV structure and revenue-share economics are not visible from the filings.
  • Analyst 2027 revenue estimate $113M (vs $95M for fiscal 2026) implies a real reacceleration if the pouch pivot lands, though the sell-side is modeling continued losses in 2027 with breakeven-plus not until 2028.
  • Insider signal is absent: zero visible insider events in this window — no operator conviction signal to offset the tape.
  • The tape confirms the caution: YTD -41%, T12M -45%, position at 22% of 52-week range and 25% below the 200-day — the market is pricing the fundamental deterioration rather than the pouch-pivot optionality.

The September 21 earnings is the fulcrum. Firm forward guidance with visible Jincheng-Pharma-JV revenue attribution, clean commentary on the vape-segment stabilization, and specific pouch-launch-timing detail pushes the framing toward turnaround; a soft segment print or specific FDA-regulatory signal validates the broken-story framing.

What to watch: September 21 earnings — firm forward guidance with visible Jincheng-Pharma-JV revenue attribution, clean commentary on the vape-segment stabilization, and specific pouch-launch-timing detail pushes the framing toward turnaround; a soft print validates broken-story framing.

On the calendar: 2026-09-21 — Q4 fiscal 2026 earnings

no sentiment

Read the AI verdict + X sentiment for $ISPR

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Manufactures OEM and branded vaping hardware for nicotine and cannabis markets, focusing on device technology and regulatory compliance.

Industry overviewAI analysisGenerated by AI from underlying data

Where Tobacco sits in its cycle right now — and what that implies for $ISPR.

Tobacco · Consumer Defensive

ETF up 2.0% today — structural driver intact: the market's trajectory under China's tightening e-cigarette regulations determines RLX's volume and pricing, while ISPR's OEM device technology for nicotine..

What this means for $ISPR

Direct beneficiary — Ispire Technology Inc.

Top industry ETF

$XLPConsumer Staples Select Sector SPDR
+8.2%YTD
+3.7%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
-2.9How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
-142%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
-37.7%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
-11.2%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
1.1Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
5.5%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
14.6%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
-0.3Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q1 2026May 7, 2026$-0.17$-0.02-750.0%
Q4 2025Feb 6, 2026$-0.12$-0.01-1100.0%
Q3 2025Nov 6, 2025$-0.06$-0.10+40.0%
Q2 2025Sep 15, 2025$-0.26$-0.14-85.7%
Next earningsMon, Sep 21·consensus EPS $-0.02

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q3 FY26$18.7M-28.7%10.7%-50.8%$-0.17$1.7M
Q2 FY26$20.3M-51.5%17.1%-33.9%$-0.12$-4.0M
Q1 FY26$30.4M-22.8%17.0%-8.9%$-0.06$-12.3M
Q4 FY25$20.1M-46.1%12.3%-72.7%$-0.26$3.7M

Forward consensus

3-year forecast · up to 1 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$94.6M$94.6M – $94.6M-$0.36-$0.36 – -$0.361
FY27$112.6M$112.6M – $112.6M-$0.03-$0.03 – -$0.031
FY28$179.0M$179.0M – $179.0M$0.03$0.03 – $0.031

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.4×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.22%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-0.5%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-25.3%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 19.6M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.4% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β2.175-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

BuyMar 2Wang Michael XueCEO3.0K sh$7KBuyFeb 27Wang Michael XueCEO2.0K sh$5KBuyFeb 26Wang Michael XueCEO2.0K sh$5KBuyFeb 25Wang Michael XueCEO4.0K sh$9KBuyFeb 24Wang Michael XueCEO2.0K sh$4KSellFeb 17Steven P. PryzbylaCLO and Secretary3.0K sh$10KSellFeb 13Steven P. PryzbylaCLO and Secretary3.0K sh$10KSellFeb 12Steven P. PryzbylaCLO and Secretary3.0K sh$10K
+ 3 other (3 awards) in window

See when $ISPR insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KShareholder voteJun 258-K — Item 5.07: Shareholder vote
AI summary

Ispire Technology held its 2026 Annual Meeting on June 23, 2026, with 52.8 million of 57.4 million eligible shares represented. All five director nominees were elected for one-year terms: Tuanfang Liu (40.5M for), Jiangyan Zhu (40.5M), Christopher Burch (40.1M), Brent Cox (39.9M), and John Fargis (40.1M), each with modest opposition. Marcum Asia LLP was also proposed for ratification as independent auditor. Routine annual governance with strong director support — no material business changes.

+ 4 other (2 proxys · 2 10-Qs) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharmaprnewswire.com·60d agoIspire Technology Q3 Earnings Call Highlightsmarketbeat.com·64d agoIspire Technology Inc. (ISPR) Q3 2026 Earnings Call Transcriptseekingalpha.com·64d agoIspire Technology Inc. (ISPR) Reports Q3 Loss, Lags Revenue Estimateszacks.com·65d agoIspire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2026prnewswire.com·65d ago

In themes

Explore the broader themes this ticker is being talked about under.

Trending on X

More in Tobacco

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$RLX
Voices on X · last 7 days

No standout posts about $ISPR on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport